Becker's Healthcare July 9, 2020
The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, on July 8 launched its COVID-19 Prevention Trials Network, a clinical trials network seeking to enroll thousands of participants in COVID-19 vaccine and antibody treatment testing.
Here are five things to know about the network:
- Four NIAID-funded clinical trials networks joined forces to form the The COVPN: the Seattle-based HIV Vaccine Trials Network, the Durham, N.C.-based HIV Prevention Trials Network, the Atlanta-based Infectious Diseases Clinical Research Consortium and the Los Angeles-based AIDS Clinical Trials Group. The HIV Vaccine Trials Network...